Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02952352 · ClinicalTrials.gov registry record · NA

Nxstan: A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men

A NA study, sponsored by Washington State University.

Completed
Registry status
NA
Development phase
113
Enrollment target

NCT02952352 is a NA study that has completed, run by Washington State University. The registered enrollment target is 113 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02952352, a NA study, has completed, sponsored by Washington State University.

COMPLETED
Registry status
NA
Development phase
113 participants
Enrollment target

Study Summary

To reduce modifiable diabetes risk factors' in overweight and obese AI men residing on the Colville reservation through a community-based, culturally informed intervention, the study specifically aims to: 1. conduct focus groups and interviews with adult members of Colville tribe to inform the adaptation, manualization and implementation of a culturally informed diabetes prevention program among overweight and obese AI men; 2. evaluate the effectiveness of a community-based, culturally informed diabetes prevention intervention by assessing between group changes.

Interventions

  • BEHAVIORAL Diabetes Prevention Program

Trial Details

FieldValue
Enrollment Target 113 participants
Start Date 2017-03-01
Est. Completion 2019-03-30
Phase NA

Sponsor

Washington State University

64 total trials

What the Registry Record Tells You About NCT02952352

The ClinicalTrials.gov registry entry for NCT02952352 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 113 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Washington State University, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Diabetes Prevention Program is the first listed.

NCT02952352 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02952352 about?

NCT02952352 is a clinical study titled "Nxstan: A Culturally Tailored Intervention to Prevent Diabetes in American Indian Men". To reduce modifiable diabetes risk factors' in overweight and obese AI men residing on the Colville reservation through a community-based, culturally informed intervention, the study specifically aims to: 1. conduct focus groups and interviews with adult members of Colville tribe to inform the adapt...

What is the current status of trial NCT02952352?

This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2017-03-01. Estimated completion is 2019-03-30.

What interventions are being tested in trial NCT02952352?

The interventions under investigation include: Diabetes Prevention Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02952352?

This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.